CClinicalTrials.gg
CompletedNCT02438267NCUpdated Mar 13, 2017

Preterm Infants and Nephrocalcinosis

An observational study in Prematurity, Nephrocalcinosis and Hypercalciuria, sponsored by University of Utah. Completed at 1 site in United States. Open to participants aged Up to 2 Weeks. Per ClinicalTrials.gov, last updated 2017-03-13.

Sponsored by University of Utah · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
56
Ages
Up to 2 Weeks
Sex
All
01

Study summary

Nephrocalcinosis (NC), defined as calcification of renal tissue, has been reported to occur in 7-41% of premature infants. Causes of NC are likely multi-factorial, and infants born prematurely and with very low birth weight (\<1500 gm) seem to be at the highest risk of developing NC. Recent changes in recommendations for nutrition for the preterm infant such as higher intakes of protein, calcium, and vitamin D may also play a factor in the pathogenesis of NC.

Currently, diagnosis of NC often occurs incidentally during ultrasound evaluation for other issues. Because there is no acute symptom or pattern of symptoms in the preterm population associated specifically with NC, it is possible that many cases of NC may not be diagnosed. Presently, it is impractical and costly to screen all infants for NC with renal ultrasound, therefore there is no standard of care regarding screening for NC.

NC may have long-term effects. Studies have shown that preterm infants with NC had shorter kidneys and a lower rate of tubule resorption of phosphorus (TRP) than preterm infants without NC.

This study will analyze weekly urinalysis for all enrolled subjects prospectively and then look at the incidence of NC at discharge of the enrolled subjects.

02

Conditions studied

  • Prematurity
  • Nephrocalcinosis
  • Hypercalciuria

Browse trials for

03

Who can participate

Ages eligible
Up to 2 Weeks
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Infants admitted to the newborn intensive care unit.

Inclusion criteria

  • Infants whose gestation less than or equal to 32 weeks and/or birth weights less than 1800 gm

Exclusion criteria

Exclusion Criteria:

  • Infants with congenital abnormalities of the heart, lung, GI, or kidneys that will affect renal function.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
56 participants (actual)
Patient registry
No

Groups and cohorts

  • Non-NC group

    Enrolled subjects who did not have evidence of NC on renal ultrasound

  • NC group

    Enrolled subjects who did have evidence of NC on renal ultrasound

05

What researchers measure

Primary outcomes

  1. Urinary calcium to creatinine ratio (UCa/Cr)

    Beginning within the first two weeks of life, urine calcium to creatinine ratio (UCa/Cr) will be analyzed weekly through discharge and then correlated to renal ultrasound results done prior to discharge.

    Time frame: 3 months

  2. Urinary crystals

    Beginning within the first two weeks of life, urinalysis for evidence of urinary crystallization will be analyzed weekly through discharge and then correlated to renal ultrasound results done prior to discharge.

    Time frame: 3 months

Secondary outcomes

  1. Serum Vitamin D levels

    Serum vitamin D levels will be analyzed and compared in infants with NC against infants without NC (controls).

    Time frame: 3 months

  2. Vitamin D intake

    Daily vitamin D intake will be recorded from participants' medical records and will be analyzed and compared in infants with NC against infants without NC (controls).

    Time frame: 3 months

  3. Calcium intake

    Daily calcium intakes will be recorded from participants' medical records and will be analyzed and compared in infants with NC against infants without NC (controls).

    Time frame: 3 months

  4. Protein intake

    Daily protein intakes will be recorded from participants' medical records and will be analyzed and compared in infants with NC against infants without NC (controls).

    Time frame: 3 months

  5. Total bone density per DXA

    Whole body bone density per dual energy X-ray absorptiometry (DXA) will be done on all enrolled participants at discharge and will be compared between infants with and without NC.

    Time frame: 3 months

  6. Tibial bone density per tibial ultrasound

    Tibial body bone density per ultrasound will be done on all enrolled participants at discharge and will be compared between infants with and without NC.

    Time frame: 3 months

06

Study locations

1 site
  • Intermountain Medical Center
    Murray, Utah 84157, United States
07

Registry details

Key details

Study ID
NCT02438267
Lead sponsor
University of Utah
Collaborators
Intermountain Health Care, Inc.
Responsible party
Sponsor
First posted
May 8, 2015
Start date
Apr 2015
Primary completion
Jan 2017
Completion
Jan 2017
Last update
Mar 13, 2017

Study contacts

Sabrina Malone-Jenkins, MD
principal investigator · University of Utah

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion